From 23 June, people living with obesity may be eligible to access tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. This does not mean prescriptions will be provided immediately. It means primary care settings can begin discussions with patients about whether tirzepatide is the right option to improve their health through weight loss.
Communities in Derbyshire that have the greatest need of help from NHS dentists are being targeted for support under a new plan.
A 35-year-old man who weighed 30 stone and had a 75% chance of a heart attack in the next 5 years, dropped two clothes sizes and five stone and changed his life on the NHS Type 2 Diabetes Path to Remission Programme.
Staff and patients at Ashgate Hospice welcomed the ICB chair Dr Kathy McLean this week for a tour of their upgraded facilities.
A review of NHS services in Glossop and the surrounding area is continuing.